Insulet Corporation

NASDAQ:PODD

Medical - Devices

Healthcare
$139.98 -2.82%

-$4.17 today

Market cap
$9.71B
Beta
1.13
P/E (TTM)
33.2
EPS (TTM)
$4.33
52W Low $140.63High $354.88

Volume 2.09M

Average 1.32M

PODD Pre-Tax Margin

Income before tax as a percentage of revenue.

Insulet CorporationNASDAQ: PODD

Pre-Tax Margin · Q2 FY2026 · quarter ended Jun 2026

Pre-tax margin widens to 14.8%

Pre-tax margin was 14.8% in Q2 FY2026, up 10.4 pp from a year earlier. On a trailing-twelve-month basis it was 16.2%, up 4.7 pp year over year. Over 3 fiscal years it widened by 11.8 pp.

Context

  • Pre-tax margin widened in 2 of the last 3 fiscal years.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJun 2026
14.8%-0.0 pp QoQ
Last fiscal yearDec 2025
12.5%-2.0 pp YoY
LTMJun 2026
16.2%+4.7 pp YoY
Pre-Tax Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter+10.4 pp——
1 year-2.0 pp——
3 years+11.8 pp——
5 years——
10 years——

Pre-Tax Margin history

Percent of revenue · from the income statement

Latest · FY2025
12.5%
Year-over-year change
-2.0pp

Pre-Tax Margin vs competitors

How PODD compares with its peers on the latest reported figures

  • PODD's LTM Jun 2026 pre-tax margin of 16.2% is the 2nd highest of the 5 companies compared; the peer median is -34.9%.
  • Its year-over-year change of +4.7 pp is the lowest of 5, against a peer median of +24.4 pp.
  • Over three fiscal years its change of +11.8 pp compares with a peer median of +0.9 pp.
PODD Competitors Peer median
Pre-Tax Margin for PODD and competitors
Company Period LTM level YoY 3-year change
DXCMDexCom, Inc.LTM Jun 202625.8% +7.5 pp+9.9 pp
PODDInsulet CorporationLTM Jun 202616.2% +4.7 pp+11.8 pp
TNDMTandem Diabetes Care, Inc.LTM Mar 2026-9.5% +6.3 pp-8.1 pp
BBNXBeta Bionics, Inc.LTM Mar 2026-60.3% +41.4 pp+36100.7 pp
SENSSenseonics Holdings, Inc.LTM Mar 2026-214.2% +98.3 pp-1063.2 pp
Peer median (excluding PODD) -34.9%+24.4 pp+0.9 pp

Competitors are the stored peer set for PODD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue1.1B1.31B1.7B2.07B2.71B
Cost of Revenue346.7M499.7M537.2M625.9M768.2M
Gross Profit752.1M805.6M1.16B1.45B1.94B
Gross Margin68.4%61.7%68.3%69.8%71.6%
Research & Development160.1M180.2M205M219.6M301.1M
Selling, General & Admin466M587.8M734.9M917.2M1.17B
Operating Expenses626.1M768M939.9M1.14B1.47B
Depreciation & Amortization57.4M63.2M72.8M80.8M90.4M
EBITDA139.6M109M323.6M423.7M509.6M
EBITDA Margin12.7%8.4%19.1%20.5%18.8%
Operating Income126M37.6M220M308.9M473.8M
Operating Margin11.5%2.9%13.0%14.9%17.5%
Interest Income500K9.3M28.6M39.5M34.7M
Interest Expense61.7M36M36.2M42.7M79.7M
Other Income / Expenses(105.5M)(27.8M)(5.4M)(8.7M)(134.3M)
Income Before Tax20.5M9.8M214.6M300.2M339.5M
Pre-Tax Margin1.9%0.8%12.6%14.5%12.5%
Income Tax Expense3.7M5.2M8.3M(118.1M)92.4M
Net Income16.8M4.6M206.3M418.3M247.1M
Net Margin1.5%0.4%12.2%20.2%9.1%
EPS (Basic)0.250.072.965.973.51
EPS (Diluted)0.250.072.945.783.48
Weighted Avg Shares67.7M69.38M69.75M70.08M70.35M
Weighted Avg Shares (Diluted)68.58M69.91M73.63M73.89M71.89M

Insulet Corporation

NASDAQ:PODD

Intrinsic Alpha fair value

Locked

Current Price

$139.98

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.